• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人巨噬细胞刺激蛋白受体RON受体酪氨酸激酶的致癌和侵袭潜能

Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.

作者信息

Wang Ming-Hai, Wang Da, Chen Yi-Qing

机构信息

Laboratory of Chang-Jiang Scholar Endowment for Biomedical Sciences, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, Peoples Republic of China.

出版信息

Carcinogenesis. 2003 Aug;24(8):1291-300. doi: 10.1093/carcin/bgg089. Epub 2003 May 22.

DOI:10.1093/carcin/bgg089
PMID:12807733
Abstract

The product of the RON (recepteur d'origine nantais) gene belongs to the MET proto-oncogene family, a distinct subfamily of receptor tyrosine kinases. The ligand of RON was identified as macrophage-stimulating protein (MSP), a member of the plasminogen-related growth factor family. RON is mainly expressed in cells of epithelial origin and is required for embryonic development. In vitro RON activation results in epithelial cell dissociation, migration and matrix invasion, suggesting that RON might be involved in the pathogenesis of certain epithelial cancers in vivo. Indeed, recent studies have shown that RON expression is significantly altered in several primary human cancers, including those of the breast and colon. Truncation of the RON protein has also been found in primary tumors from the gastrointestinal tract. These alterations lead to constitutive activation of RON that causes cell transformation in vitro, induces neoplasm formation in athymic nude mice, and promotes tumor metastasis into the lung. Studies employing transgenic models further demonstrated that over-expression of RON in lung epithelial cells results in multiple tumor formation with features of large cell undifferentiated carcinoma. The oncogenic activities of RON are mediated by RON-transduced signals that promote unbalanced cell growth and transformation leading to tumor development. Thus, abnormal accumulation and activation of RON could play a critical role in vivo in the progression of certain malignant human epithelial cancers.

摘要

RON(源自南特的受体)基因的产物属于MET原癌基因家族,是受体酪氨酸激酶的一个独特亚家族。RON的配体被确定为巨噬细胞刺激蛋白(MSP),它是纤溶酶原相关生长因子家族的成员。RON主要在上皮来源的细胞中表达,是胚胎发育所必需的。在体外,RON激活会导致上皮细胞解离、迁移和基质侵袭,这表明RON可能在体内某些上皮癌的发病机制中起作用。事实上,最近的研究表明,RON的表达在几种原发性人类癌症中显著改变,包括乳腺癌和结肠癌。在胃肠道的原发性肿瘤中也发现了RON蛋白的截短。这些改变导致RON的组成性激活,在体外引起细胞转化,在无胸腺裸鼠中诱导肿瘤形成,并促进肿瘤转移到肺部。采用转基因模型的研究进一步证明,肺上皮细胞中RON的过度表达会导致具有大细胞未分化癌特征的多个肿瘤形成。RON的致癌活性由RON转导的信号介导,这些信号促进不平衡的细胞生长和转化,导致肿瘤发展。因此,RON的异常积累和激活可能在体内某些人类恶性上皮癌的进展中起关键作用。

相似文献

1
Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.人巨噬细胞刺激蛋白受体RON受体酪氨酸激酶的致癌和侵袭潜能
Carcinogenesis. 2003 Aug;24(8):1291-300. doi: 10.1093/carcin/bgg089. Epub 2003 May 22.
2
Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.RON受体酪氨酸激酶的肿瘤发生:恶性上皮性癌的分子靶点
Acta Pharmacol Sin. 2006 Jun;27(6):641-50. doi: 10.1111/j.1745-7254.2006.00361.x.
3
Oncogenic signaling pathways activated by RON receptor tyrosine kinase.由RON受体酪氨酸激酶激活的致癌信号通路。
Curr Cancer Drug Targets. 2003 Feb;3(1):31-40. doi: 10.2174/1568009033333745.
4
RON, a tyrosine kinase receptor involved in tumor progression and metastasis.RON是一种参与肿瘤进展和转移的酪氨酸激酶受体。
Ann Surg Oncol. 2005 Apr;12(4):273-81. doi: 10.1245/ASO.2005.08.013. Epub 2005 Mar 15.
5
The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells.RON受体酪氨酸激酶促进乳腺上皮细胞中不依赖于巨噬细胞刺激蛋白的细胞铺展和存活。
Oncogene. 2009 Jan 15;28(2):279-88. doi: 10.1038/onc.2008.383. Epub 2008 Oct 6.
6
Structural basis for the binding specificity of human Recepteur d'Origine Nantais (RON) receptor tyrosine kinase to macrophage-stimulating protein.人源南特起源受体(RON)受体酪氨酸激酶与巨噬细胞刺激蛋白结合特异性的结构基础
J Biol Chem. 2014 Oct 24;289(43):29948-60. doi: 10.1074/jbc.M114.594341. Epub 2014 Sep 5.
7
Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.源自南特的酪氨酸激酶受体是缺氧诱导因子-1α介导的乳腺癌细胞侵袭的直接靶点。
J Biol Chem. 2009 May 22;284(21):14001-10. doi: 10.1074/jbc.M809320200. Epub 2009 Mar 23.
8
Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.鉴定一种具有体内抗肿瘤活性的新型南特受体/ c- met小分子激酶抑制剂。
Cancer Res. 2008 Aug 15;68(16):6680-7. doi: 10.1158/0008-5472.CAN-07-6782.
9
Macrophage stimulating protein preserves blood brain barrier integrity after intracerebral hemorrhage through recepteur d'origine nantais dependent GAB1/Src/β-catenin pathway activation in a mouse model.巨噬细胞刺激蛋白通过在小鼠模型中激活受体源性南特依赖的 GAB1/Src/β-连环蛋白通路,在脑出血后保持血脑屏障的完整性。
J Neurochem. 2019 Jan;148(1):114-126. doi: 10.1111/jnc.14622. Epub 2018 Dec 5.
10
Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.巨噬细胞刺激蛋白与转化生长因子-β1 在诱导上皮-间质转化中的协同作用:RON 受体酪氨酸激酶的作用
Oncogene. 2004 Mar 4;23(9):1668-80. doi: 10.1038/sj.onc.1207282.

引用本文的文献

1
MSP-RON signaling in liver pathobiology and as an emerging therapeutic target: a review of the current evidence.MSP-RON信号通路在肝脏病理生物学中的作用及作为新兴治疗靶点的研究现状:现有证据综述
Cell Commun Signal. 2025 Aug 28;23(1):385. doi: 10.1186/s12964-025-02407-5.
2
Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer.靶向受体酪氨酸激酶作为一种治疗三阴性乳腺癌的新策略。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241234780. doi: 10.1177/15330338241234780.
3
Discovery of novel conjugates of quinoline and thiazolidinone urea as potential anti-colorectal cancer agent.
发现新型喹啉和噻唑烷二酮脲的缀合物作为潜在的抗结直肠癌药物。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):2334-2347. doi: 10.1080/14756366.2022.2117318.
4
The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies.癌症中的MST1R/RON酪氨酸激酶:致癌功能与治疗策略
Cancers (Basel). 2022 Apr 18;14(8):2037. doi: 10.3390/cancers14082037.
5
Identification of pancreatic cancer type related factors by Weighted Gene Co-Expression Network Analysis.基于加权基因共表达网络分析鉴定胰腺癌类型相关因素。
Med Oncol. 2020 Mar 21;37(4):33. doi: 10.1007/s12032-020-1339-0.
6
Lysophosphatidic Acid Upregulates Recepteur D'origine Nantais Expression and Cell Invasion via Egr-1, AP-1, and NF-κB Signaling in Bladder Carcinoma Cells.溶血磷脂酸通过 Egr-1、AP-1 和 NF-κB 信号通路上调膀胱癌细胞中 Recepteur D'origine Nantais 的表达和细胞侵袭。
Int J Mol Sci. 2020 Jan 1;21(1):304. doi: 10.3390/ijms21010304.
7
Piperidine carbamate peptidomimetic inhibitors of the serine proteases HGFA, matriptase and hepsin.丝氨酸蛋白酶HGFA、matriptase和hepsin的哌啶氨基甲酸酯拟肽抑制剂。
Medchemcomm. 2019 Jul 18;10(9):1646-1655. doi: 10.1039/c9md00234k. eCollection 2019 Sep 1.
8
RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells.RON 受体酪氨酸激酶通过 Src/Smad 信号通路调节 HK-2 和 NRK49F 细胞的上皮间质转化和促纤维化标志物的表达。
Int J Mol Sci. 2019 Nov 4;20(21):5489. doi: 10.3390/ijms20215489.
9
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?当间皮瘤中的RON遇上TAM:是否所有靶点都可针对一种药物,而一种药物能针对所有靶点?
Front Endocrinol (Lausanne). 2019 Feb 26;10:89. doi: 10.3389/fendo.2019.00089. eCollection 2019.
10
mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential.mTORC1是具有治疗潜力的RON依赖性乳腺癌转移的关键介质。
NPJ Breast Cancer. 2018 Nov 9;4:36. doi: 10.1038/s41523-018-0091-5. eCollection 2018.